DE69834937D1 - Antibiotika zur behandlung von magengeschwuren - Google Patents

Antibiotika zur behandlung von magengeschwuren

Info

Publication number
DE69834937D1
DE69834937D1 DE69834937T DE69834937T DE69834937D1 DE 69834937 D1 DE69834937 D1 DE 69834937D1 DE 69834937 T DE69834937 T DE 69834937T DE 69834937 T DE69834937 T DE 69834937T DE 69834937 D1 DE69834937 D1 DE 69834937D1
Authority
DE
Germany
Prior art keywords
stomaches
antibiotics
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69834937T
Other languages
English (en)
Inventor
Masaru Sato
Makoto Hadano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai Co Ltd
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Application granted granted Critical
Publication of DE69834937D1 publication Critical patent/DE69834937D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE69834937T 1997-09-17 1998-09-03 Antibiotika zur behandlung von magengeschwuren Expired - Lifetime DE69834937D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25255297 1997-09-17
PCT/JP1998/003940 WO1999013872A1 (fr) 1997-09-17 1998-09-03 Produits antimicrobiens

Publications (1)

Publication Number Publication Date
DE69834937D1 true DE69834937D1 (de) 2006-07-27

Family

ID=17238966

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69834937T Expired - Lifetime DE69834937D1 (de) 1997-09-17 1998-09-03 Antibiotika zur behandlung von magengeschwuren

Country Status (8)

Country Link
US (3) US6426369B1 (de)
EP (1) EP1033129B1 (de)
KR (1) KR100550839B1 (de)
CN (1) CN1141089C (de)
CA (1) CA2302251A1 (de)
DE (1) DE69834937D1 (de)
HK (1) HK1030371A1 (de)
WO (1) WO1999013872A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098398A1 (en) * 2001-06-07 2002-12-12 Eisai Co., Ltd. Methods for preventing and treating diseases and conditions associated with cellular stress
EP1611901B1 (de) * 2003-03-13 2013-07-10 Eisai R&D Management Co., Ltd. Mittel zur Prävention oder Heilung von Zähneknirschen
US20100297226A1 (en) * 2006-06-01 2010-11-25 Dexcel Pharma Technologies Ltd. Multiple unit pharmaceutical formulation
US20150238473A1 (en) 2012-09-27 2015-08-27 University Of Rochester Methods and compositions for treating infection
EP3050565A1 (de) * 2015-01-27 2016-08-03 Ecole Polytechnique Fédérale de Lausanne (EPFL) Benzimidazolschwefelderivate zur Vorbeugung oder Behandlung von Tuberkulose
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
CN106619591B (zh) * 2015-11-04 2019-07-05 中国科学院武汉病毒研究所 奥昔卡因在制备药物中的用途及药物组合物
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
US11890295B2 (en) 2018-08-31 2024-02-06 Korea Institute Of Geoscience And Mineral Resources Helicobacter pylori eradication method including step for orally administering composition including complex of non-absorbable antibiotic and clay mineral to subject
CN111904957A (zh) * 2020-09-04 2020-11-10 郑州大学 奥昔卡因在制备抗肿瘤药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5665825A (en) * 1979-10-31 1981-06-03 Mochida Pharmaceut Co Ltd Remedy for peptic ulcer
US5811547A (en) * 1992-10-14 1998-09-22 Nippon Shinyaju Co., Ltd. Method for inducing crystalline state transition in medicinal substance
DE69614097T2 (de) * 1995-03-17 2002-03-14 Boots Co Ltd Flüssige pharmazeutische zusammensetzungen mit pektin
DE69613966T2 (de) * 1995-03-17 2002-04-04 Boots Co Ltd Pharmazeutische zusammensetzungen mit pektin
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
GB2368013B (en) * 2001-02-19 2004-07-28 Richard Orlando Brown An antacid composition which comprise multiple pharmacologically active ingredients for the symptomatic management of pain

Also Published As

Publication number Publication date
HK1030371A1 (en) 2001-05-04
EP1033129B1 (de) 2006-06-14
CA2302251A1 (en) 1999-03-25
US6426369B1 (en) 2002-07-30
US6740667B2 (en) 2004-05-25
KR100550839B1 (ko) 2006-02-10
US20030216438A1 (en) 2003-11-20
KR20010024050A (ko) 2001-03-26
CN1270517A (zh) 2000-10-18
CN1141089C (zh) 2004-03-10
EP1033129A1 (de) 2000-09-06
US20030069279A1 (en) 2003-04-10
EP1033129A4 (de) 2003-11-12
WO1999013872A1 (fr) 1999-03-25

Similar Documents

Publication Publication Date Title
ATE235481T1 (de) Substituierte benzopyranderivate zur behandlung von entzündungen
DE69812681D1 (de) Unsubstituierte polydiallylaminen zur behandlung von hypercholesterolemia
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE69806579D1 (de) Anlage zur behandlung von nahrungsmitteln
DE69821667D1 (de) Kardioverter zur Behandlung von Vorhofflattern
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
DE69807466T2 (de) Triptolid-derivate nützlich zur behandlung von autoimmunkrankheiten
ATE347372T1 (de) Vakzine zur behandlung von mycosen
DE69834937D1 (de) Antibiotika zur behandlung von magengeschwuren
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
DE60001255D1 (de) Zusammensetzung zur Behandlung von Polyesterfaser
DE69822297D1 (de) Triptolid-derivate geeignet zur behandlung von autoimmunkrankheiten
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
ATE235494T1 (de) Imino-aza-anthracyclonderivate zur behandlung von amyloidosis
ATE218866T1 (de) Kombinationstherapie zur behandlung von aids
DE69408394D1 (de) 4-Piperidino-piperidin zur Behandlung von Tumoren
ATA93695A (de) Mittel zur behandlung von strahlenschäden
DE69802300D1 (de) Behandlung von schädlichen flüssigkeiten
DE69819503D1 (de) Verwendung von 7-apha-methyl-17-alpha-ethynyl-estrane derivaten zur behandlung von atherosclerose
DE69731981D1 (de) Neue verbesserte formulierung zur behandlung von thromboembolismus
DE59803609D1 (de) Behandlung von Kunststoffoberflächen

Legal Events

Date Code Title Description
8332 No legal effect for de